NCT06305962 2026-02-19177Lu-anti-PD-L1 sdAb in Metastatic Solid TumorsRadiopharm Theranostics, LtdPhase EARLY_PHASE1 Recruiting30 enrolled
NCT03514121 2024-11-22FPA150-001Five Prime Therapeutics, Inc.Phase EARLY_PHASE1 Terminated95 enrolled 36 charts
NCT02646319 2019-06-06Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR MutationsMayo ClinicPhase EARLY_PHASE1 Completed2 enrolled